292 related articles for article (PubMed ID: 25034973)
1. p38 mitogen-activated protein kinase is involved in arginase-II-mediated eNOS-uncoupling in obesity.
Yu Y; Rajapakse AG; Montani JP; Yang Z; Ming XF
Cardiovasc Diabetol; 2014 Jul; 13():113. PubMed ID: 25034973
[TBL] [Abstract][Full Text] [Related]
2. Role of p38 mitogen-activated protein kinase in vascular endothelial aging: interaction with Arginase-II and S6K1 signaling pathway.
Wu Z; Yu Y; Liu C; Xiong Y; Montani JP; Yang Z; Ming XF
Aging (Albany NY); 2015 Jan; 7(1):70-81. PubMed ID: 25635535
[TBL] [Abstract][Full Text] [Related]
3. Uncoupling of Endothelial Nitric Oxide Synthase in Perivascular Adipose Tissue of Diet-Induced Obese Mice.
Xia N; Horke S; Habermeier A; Closs EI; Reifenberg G; Gericke A; Mikhed Y; Münzel T; Daiber A; Förstermann U; Li H
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):78-85. PubMed ID: 26586660
[TBL] [Abstract][Full Text] [Related]
4. Positive crosstalk between arginase-II and S6K1 in vascular endothelial inflammation and aging.
Yepuri G; Velagapudi S; Xiong Y; Rajapakse AG; Montani JP; Ming XF; Yang Z
Aging Cell; 2012 Dec; 11(6):1005-16. PubMed ID: 22928666
[TBL] [Abstract][Full Text] [Related]
5. p38 Mitogen-activated protein kinase is required for glucosamine-induced endothelial nitric oxide synthase uncoupling and plasminogen-activator inhibitor expression.
Wu Z; Xiong Y; Gajanayake T; Ming XF; Yang Z
Circ J; 2012; 76(8):2015-22. PubMed ID: 22572461
[TBL] [Abstract][Full Text] [Related]
6. p32-Dependent p38 MAPK Activation by Arginase II Downregulation Contributes to Endothelial Nitric Oxide Synthase Activation in HUVECs.
Koo BH; Won MH; Kim YM; Ryoo S
Cells; 2020 Feb; 9(2):. PubMed ID: 32046324
[TBL] [Abstract][Full Text] [Related]
7. Caloric restriction reverses high-fat diet-induced endothelial dysfunction and vascular superoxide production in C57Bl/6 mice.
Ketonen J; Pilvi T; Mervaala E
Heart Vessels; 2010 May; 25(3):254-62. PubMed ID: 20512454
[TBL] [Abstract][Full Text] [Related]
8. Regulation of MAP kinase-mediated endothelial dysfunction in hyperglycemia via arginase I and eNOS dysregulation.
Mazrouei S; Sharifpanah F; Caldwell RW; Franz M; Shatanawi A; Muessig J; Fritzenwanger M; Schulze PC; Jung C
Biochim Biophys Acta Mol Cell Res; 2019 Sep; 1866(9):1398-1411. PubMed ID: 31150695
[TBL] [Abstract][Full Text] [Related]
9. Arginase upregulation and eNOS uncoupling contribute to impaired endothelium-dependent vasodilation in a rat model of intrauterine growth restriction.
Grandvuillemin I; Buffat C; Boubred F; Lamy E; Fromonot J; Charpiot P; Simoncini S; Sabatier F; Dignat-George F; Peyter AC; Simeoni U; Yzydorczyk C
Am J Physiol Regul Integr Comp Physiol; 2018 Sep; 315(3):R509-R520. PubMed ID: 29741931
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of p38mapk Reduces Adipose Tissue Inflammation in Aging Mediated by Arginase-II.
Huang J; Liu C; Ming XF; Yang Z
Pharmacology; 2020; 105(9-10):491-504. PubMed ID: 32454488
[TBL] [Abstract][Full Text] [Related]
11. Arginase Inhibition Restores Peroxynitrite-Induced Endothelial Dysfunction via L-Arginine-Dependent Endothelial Nitric Oxide Synthase Phosphorylation.
Nguyen MC; Park JT; Jeon YG; Jeon BH; Hoe KL; Kim YM; Lim HK; Ryoo S
Yonsei Med J; 2016 Nov; 57(6):1329-38. PubMed ID: 27593859
[TBL] [Abstract][Full Text] [Related]
12. Arginase II protein regulates Parkin-dependent p32 degradation that contributes to Ca2+-dependent eNOS activation in endothelial cells.
Koo BH; Won MH; Kim YM; Ryoo S
Cardiovasc Res; 2022 Mar; 118(5):1344-1358. PubMed ID: 33964139
[TBL] [Abstract][Full Text] [Related]
13. Arginase inhibition by rhaponticin increases L-arginine concentration that contributes to Ca
Koo BH; Lee J; Jin Y; Lim HK; Ryoo S
BMB Rep; 2021 Oct; 54(10):516-521. PubMed ID: 34078530
[TBL] [Abstract][Full Text] [Related]
14. Genetic Targeting of Arginase-II in Mouse Prevents Renal Oxidative Stress and Inflammation in Diet-Induced Obesity.
Huang J; Rajapakse A; Xiong Y; Montani JP; Verrey F; Ming XF; Yang Z
Front Physiol; 2016; 7():560. PubMed ID: 27920727
[TBL] [Abstract][Full Text] [Related]
15. p38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated mice.
Toque HA; Romero MJ; Tostes RC; Shatanawi A; Chandra S; Carneiro ZN; Inscho EW; Webb RC; Caldwell RB; Caldwell RW
J Sex Med; 2010 Dec; 7(12):3857-67. PubMed ID: 20807329
[TBL] [Abstract][Full Text] [Related]
16. Akita spontaneously type 1 diabetic mice exhibit elevated vascular arginase and impaired vascular endothelial and nitrergic function.
Toque HA; Nunes KP; Yao L; Xu Z; Kondrikov D; Su Y; Webb RC; Caldwell RB; Caldwell RW
PLoS One; 2013; 8(8):e72277. PubMed ID: 23977269
[TBL] [Abstract][Full Text] [Related]
17. Arginase II Contributes to the Ca
Koo BH; Hwang HM; Yi BG; Lim HK; Jeon BH; Hoe KL; Kwon YG; Won MH; Kim YM; Berkowitz DE; Ryoo S
J Am Heart Assoc; 2018 Sep; 7(18):e009579. PubMed ID: 30371203
[TBL] [Abstract][Full Text] [Related]
18. Arginase-I enhances vascular endothelial inflammation and senescence through eNOS-uncoupling.
Zhu C; Yu Y; Montani JP; Ming XF; Yang Z
BMC Res Notes; 2017 Feb; 10(1):82. PubMed ID: 28153047
[TBL] [Abstract][Full Text] [Related]
19. A Novel Arginase Inhibitor Derived from Scutellavia indica Restored Endothelial Function in ApoE-Null Mice Fed a High-Cholesterol Diet.
Hwang HM; Lee JH; Min BS; Jeon BH; Hoe KL; Kim YM; Ryoo S
J Pharmacol Exp Ther; 2015 Oct; 355(1):57-65. PubMed ID: 26265320
[TBL] [Abstract][Full Text] [Related]
20. Arginase-II induces vascular smooth muscle cell senescence and apoptosis through p66Shc and p53 independently of its l-arginine ureahydrolase activity: implications for atherosclerotic plaque vulnerability.
Xiong Y; Yu Y; Montani JP; Yang Z; Ming XF
J Am Heart Assoc; 2013 Jul; 2(4):e000096. PubMed ID: 23832324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
